Olmesartan Medoxomil
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00275 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Prinzmetal angina | KG + DL |
| 2 | hypotrichosis simplex of the scalp | KG + DL |
| 3 | migraine disorder | KG + DL |
| 4 | alopecia | KG + DL |
| 5 | pulmonary hypertension | KG + DL |
| 6 | congenital hypotrichosis milia | KG + DL |
| 7 | diffuse alopecia areata | KG + DL |
| 8 | migraine with brainstem aura | KG + DL |
| 9 | kyphoscoliotic heart disease | KG + DL |
| 10 | open-angle glaucoma | KG + DL |
| 11 | homozygous familial hypercholesterolemia | KG + DL |
| 12 | primary hereditary glaucoma | KG + DL |
| 13 | Raynaud disease | KG + DL |
| 14 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 15 | peripheral vascular disease | KG + DL |
| 16 | hypertensive disorder | KG + DL |
| 17 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 18 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 19 | migraine with or without aura, susceptibility to | KG + DL |
| 20 | malignant hypertensive renal disease | KG + DL |
| 21 | malignant renovascular hypertension | KG + DL |
| 22 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 23 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 24 | hyperthyroidism | KG + DL |
| 25 | peripheral arterial disease | KG + DL |
| 26 | Braddock syndrome | KG + DL |
| 27 | pseudopelade of Brocq | KG + DL |
| 28 | intermittent vascular claudication | KG + DL |
| 29 | intracranial arteriosclerosis | KG + DL |
| 30 | diabetic nephropathy | KG + DL |
| 31 | cor pulmonale | KG + DL |
| 32 | atrophoderma vermiculata | KG + DL |
| 33 | headache disorder | KG + DL |
| 34 | ulerythema ophryogenesis | KG + DL |
| 35 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 36 | Graves disease | KG + DL |
| 37 | hypotrichosis of eyelid | KG + DL |
| 38 | myocardial infarction | KG + DL |
| 39 | chronic pulmonary heart disease | KG + DL |
| 40 | trigeminal autonomic cephalalgia | KG + DL |
| 41 | Monckeberg arteriosclerosis | KG + DL |
| 42 | neonatal thyrotoxicosis | KG + DL |
| 43 | hemoglobinopathy | KG + DL |
| 44 | hypoalphalipoproteinemia | KG + DL |
| 45 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 46 | vascular disease | KG + DL |
| 47 | posteroinferior myocardial infarction | KG + DL |
| 48 | posterolateral myocardial infarction | KG + DL |
| 49 | septal myocardial infarction | KG + DL |
| 50 | visceral calciphylaxis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.